Methylprednisolone alleviates multiple sclerosis by expanding myeloid‐derived suppressor cells via glucocorticoid receptor β and S100A8/9 up‐regulation

Methylprednisolone is an effective drug in the treatment of autoimmune disease, such as multiple sclerosis (MS), due to long‐acting anti‐inflammatory, antiallergic and immunosuppressant. Previous studies have noted the importance of myeloid‐derived suppressor cells (MDSC) in MS progression. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhongkun, Zheng, Ge, Li, Guangjian, Wang, Mengkun, Ma, Zhanchuan, Li, Huimin, Wang, Xiang‐Yang, Yi, Huanfa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753844/
https://www.ncbi.nlm.nih.gov/pubmed/33094923
http://dx.doi.org/10.1111/jcmm.15928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753844/
https://www.ncbi.nlm.nih.gov/pubmed/33094923
http://dx.doi.org/10.1111/jcmm.15928

Ejemplares similares